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Objectives: The aim of this study was to develop an immunochromatographic
assay (ICA) for the detection of influenza A (H1N1) pdm09 virus infection.
Materials and methods: Several monoclonal antibodies against influenza A
(H1N1) pdm09 virus were generated and an ICA (pdm09-ICA) was developed for
the rapid and specific detection of influenza A (H1N1) pdm09 virus infection. The
specificity and sensitivity of the developed assay were compared with that of
hemagglutination assay and real-time reverse-transcription polymerase chain
reaction (rRT-PCR).
Results: The detection limit was estimated to be 1/2 (8) hemagglutinating unit;
the sensitivity and specificity rates of pdm09-ICA were 75.86% (110/145) and
100% (43/43), respectively, compared with rRT-PCR. The cross-reactivity for 20
influenza viruses, including seasonal H1N1 viruses, was found to be negative
except for the H1N1 virus (A/Swine/Korea/GC0503/2005).
Conclusion: These results indicate that the proposed method can be easily used
for rapid and specific detection of the pdm09 infection. The assay developed in
this study would be a useful tool for distinguishing the pdm09 infection from
seasonal influenza A and B infections.ted under the terms of the Creative Commons Attribution Non-Commercial License (http://
) which permits unrestricted non-commercial use, distribution, and reproduction in any
operly cited.
ase Control and Prevention. Published by Elsevier Korea LLC. All rights reserved.
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The influenza A (H1N1) pdm09 virus (pdm09) was
first reported in the spring of 2009 in Mexico and in the
United States. The virus spreads rapidly and its infection
has become a world pandemic [1,2]. In August 2010, the
World Health Organization (WHO) announced the
postpandemic period. However, WHO recommended
that the pdm09 virus is expected to continue as a sea-
sonal virus. According to the report, younger age groups
and pregnant women will continue to be affected
disproportionately from the pdm09 infection [3].
The Centers for Disease Control and Prevention
recommends using the real-time reverse-transcription
polymerase chain reaction (rRT-PCR) analysis for the
confirmation of pdm09 infection [4]. Although rRT-
PCR is a standard method and is highly sensitive and
specific for the detection of influenza viruses [5e7], it
requires specialized equipment, trained technicians, and
takes more than 5e24 hours to generate results from
clinical specimens [1,7,8]; in addition, rRT-PCR is
available only in limited diagnostic laboratories [9,10].
Even though commercial influenza antigen tests can
distinguish between influenza A and B viruses, they are
unable to differentiate between the pdm09 and seasonal
influenza A viruses [4].
Detection of pdm09-specific hemagglutinin (HA) gene
can be used for the confirmation of pdm09 virus and for
differentiating it from other seasonal influenza viruses [7].
Thus, antibodies against this HA can be useful agents to
develop methods that can distinguish between the pdm09
and the seasonal influenza A and B viruses.
In this study, we have developed monoclonal anti-
bodies against the HA of pdm09 virus and a rapid antigen
test specifically to detect pdm09 based on the principle of
immunochromatographic assay (pdm09-ICA).2. Materials and methods
2.1. Patient and clinical specimens
During the period from October 2009 to November
2009, two nasopharyngeal swab specimens were
collected simultaneously using flocked swabs (Copan
Diagnostics, Murrieta, CA, USA) from each patient
(n Z 188) at the Cheonan Hospital (Soonchunhyang
University, Korea). One specimen was placed in a tube
containing 0.3 mL of assay buffer for pdm09-ICA, and
the other was placed in a tube containing 1 mL of viral
transport medium for rRT-PCR.
2.2. Preparation of pdm09
The pdm09 virus strain (A/Korea/01/2009) was ob-
tained from the Korea Centers for Disease Control and
Prevention. A total of 25 hemagglutinating units (HAU)
of the binary ethylenimine-inactivated pdm09 were
centrifuged at 4000  g for 30 minutes at 4 C;their supernatants were harvested and centrifuged at
70,000 g for 3 hours at 4 C (L8-70M; Beckman, USA).
The pellets were resuspended with 1% sucrose solution,
followed by ultracentrifugation on a discontinuous su-
crose density gradient, as described previously [11].
Moreover, fractions that displayed hemagglutinationwith
1% chicken red blood cell were collected to be used as
antigen in the monoclonal antibody preparation process.
2.3. Production of mouse monoclonal antibodies
against pdm09
Hybridoma producing mouse monoclonal antibody
(MAb) against the pdm09 virus was prepared as follows:
female BALB/c mice, 7 weeks of age, were intraperito-
neally immunized with 200 mg of concentrated pdm09.
They were emulsified in complete Freund’s adjuvant
(Sigma-Aldrich, St. Louis,USA) for the first immunization
and in incomplete Freund’s adjuvant for the second and
third immunizations at 1-week intervals. Spleen cells of the
immunized mice were fused with SP2/0 myeloma cells
using polyethyleneglycol 1500 (RocheDiagnosticsGmbH,
Mannheim, Germany). The hybridomas, which secrete
specific antibodies against theHA of the pdm09 virus, were
screened using the hemagglutination inhibition (HI) assay.
Cell culture supernatants of the hybridomas were diluted in
phosphate-buffered saline (pH 7.2) at a ratio of 1:1, and 22
HAU of the pdm09 cells were mixed and incubated for
30 minutes at room temperature (RT). Approximately 1%
chicken red blood cell was added and the mixture was
incubated for 30 minutes at RT. Finally, hybridomas that
completely inhibited the hemagglutination were selected.
In the screening test, hybridomas producing positive
monoclonal antibodies were subcloned by limiting the
dilution, and were grown as ascites-producing tumors in
the peritoneal cavities of Freund’s adjuvant-primed
BALB/c mice. The monoclonal antibodies were puri-
fied from the ascites fluid by chromatography on protein
G-Sepharose 4B fast flow medium (GE Healthcare Bio-
Sciences, Uppsala, Sweden).
2.4. Development of pdm09-ICA
The pdm09-ICA, which was developed for the
detection of pdm09 using monoclonal antibodies, is
specific to the pdm09 virus. The test strip includes a
sample pad, a gold conjugate pad, a nitrocellulose
membrane (Millipore Co., USA), and an absorbent pad.
The captured antibodies were immobilized to two
different lines on a nitrocellulose membrane, namely,
the control line (1.0 mg/mL goat antimouse immuno-
globulin G) and the test (2.0 mg/mL pdm09 MAb).
Detector antibodies were conjugated with colloidal gold
particles (Standard Diagnostic, Korea) and the gold-
conjugated pdm09 MAb were dried on a glass fiber.
Samples were diluted with assay buffer (0.4 M Tricine,
0.1 M NaCl, and 1% TritonX-100) in test tubes, and the
test strips were added into the test tube. The pdm09 was
combined with the antibodyecolloidal gold conjugates,
Figure 1. Specific detection of the influenza A (H1N1)
pdm09 virus by pdm09-ICA. The result is negative if only one
purple band appears, whereas it is positive if two purple bands
appear. ICA Z immunochromatographic assay.
Table 2. Specificity of pdm09-ICA for 20 different
influenza viruses
Type Strain HAU
Pdm09-ICA
results
H1N1 A/PR/8/34 27 e
A/Brisbane/59/2007 27 e
A/Solomon
Islands/3/2006
28 e
A/New Caledonia/
20/99
27 e
A/Swine/Korea/
GC0503/2005
26 
7
344 M.J. Ji, et aland complexes were migrated to the immobilized anti-
bodies. The positive samples showed a purple band,
whereas the negative samples did not.
2.5. rRT-PCR
The viral RNA was extracted using a QIAamp viral
RNA minikit (Qiagen, Germany), according to the manu-
facturer’s instructions. Each reactionmixture for rRT-PCR
was prepared according to the manufacturer’s instructions,
and includes 5 mL of extracted RNA and PCR reagents
(Influenza A/H1N1Detection set; Roche Applied Science,
Germany). Amplification and detectionwere conducted on
LightCycler 480 (Roche Applied Science).
H2N2 A/Singapore/1/57 2 e
H3N2 A/Hong Kong/8/68 26 e
H3N5 A/Swine/Korea/
GC0407/2005
27 e
H3N8 A/Duck/Ukraine/1/63 25 e
H4N6 A/Duck/
Czechoslovakia/56
27 e
H5N3 A/Duck/Hong Kong/
820/80
26 e
73. Results
3.1. Production of anti-pdm09 monoclonal
antibodies
Mice were immunized with pdm09 emulsified with
incomplete Freund’s adjuvant. Spleens of mice showingTable 1. Analytical sensitivity of pdm09-ICA
Dilution (HAU) Hemagglutination assay pdm09-ICA
1:2 (21) þ þþþ
1:4 (22) þ þþ
1:8 (23) þ þþ
1:16 (24) þ þ
1:32 (25) e þ
1:64 (26) e þw
1:128 (27) e 
1:256 (28) e 
1:512 (29) e e
þ Z positive; þþ Z medium positive; þþþ Z strong positive;
þw Z weak positive;  Z trace; e Z negative;
HAUZ hemagglutinating units; ICAZ immunochromatographic assay.seroreactivity to the pdm09 virus were isolated and
fused to myeloma cells. Specific antibodies against the
pdm09 virus were selected by the HI assay, which was
conducted with the pdm09 and seasonal H1N1 viruses.
Ten anti-pdm09 antibodies reacted with pdm09, but did
not react with the seasonal H1N1. The selected anti-
bodies were produced as ascites of BALB/c mice and
purified from the ascites fluid by protein G-affinity resin.
Two clones, i38 and d383, showing high reactivity to-
ward pdm09 were selected for pdm09-ICA.3.2. Development of pdm09-ICA
These 10 antibodies were paired by negative and
positive reference specimens (data not shown). The pair
of i38 antibody (as capture) and d383 antibody (as de-
tector) had different signals in the negative and positive
specimens. The i38 antibody was coated on a nitrocel-
lulose membrane as the test line, and the d383 antibody
was conjugated with colloidal gold particles.H6N5 A/Shearwater/
Australia/1/72
2 e
H7N1 A/Duck/Hong Kong/
301/78
24 e
H8N4 A/Turkey/Ontario/
6118/68
26 e
H9N2 A/Turkey/Wisconsin/
1/66
28 e
H10N7 A/Chicken/Germany/
N/49
27 e
H10N9 A/Duck/Hong Kong/
562/1979
28 e
H11N6 A/Duck/England/56 28 e
H11N8 A/Duck/Hong Kong/
T37/97
27 e
B B/Lee/40 25 e
HAU Z hemagglutinating units; ICA Z immunochromatographic
assay.
Table 3. Performance of pdm09-ICA compared with real-time RT-PCR
Real-time
PCR resultsa (nb)
No. of specimens with pdm09-ICA
% Clinical
sensitivity (95% CI)
% Clinical
specificity (95% CI) PPV (%) NPV (%)Positive Negative
Confirmed
positive (145)
110 35 75.86 (68.29e82.1) d 100 d
Confirmed
negative (43)
0 43 d 100 (91.8e100) d 55.1
aAs determined by Roche real-time PCR; bn, Number of specimens with result. CI Z confidence interval; ICA Z immunochromatographic assay;
NPV Z negative predictive value; PPV Z positive predictive value; RT-PCR Z reverse-transcription polymerase chain reaction.
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Further, the test strips were added into the test tube and
the results were read for 10e15 minutes (Figure 1).
3.3. Performance evaluation of pdm09-ICA
The sensitivity of the pdm09-ICA was compared with
the hemagglutination assay. In brief, the hemagglutina-
tion assay was carried as follows: the pdm09 (A/Korea/
01/2009) was diluted twofold in phosphate-buffered
saline (pH 7.2), and 1% chicken red blood cell was
added into the diluted pdm09, which was then mixed
and incubated for 40 minutes at RT. To investigate the
sensitivity of the pdm09-ICA, twofold dilutions of the
pdm09 were made in assay buffer and applied to the test
strip. The detection limit of the pdm09-ICA was esti-
mated at 1/2 (8) HAU, and the detection limit of the
hemagglutination assay was 1/2 (4) HAU (Table 1). The
result of the pdm09-ICA showed relatively high sensi-
tivity than the hemagglutination assay.
A total of 20 influenza viruses, including the seasonal
H1N1 virus, were confirmed with cross-reactivity of the
pdm09-ICA for specificity of the pdm09. No positive
signal was shown except for the H1N1 (A/Swine/Korea/
GC0503/2005), which had a very weak positive signal
(Table 2).
We evaluated the sensitivity and specificity of the
pdm09-ICA to the pdm09 using clinical specimens
consisting of 145 positive and 43 negative specimens,
confirmed by rRT-PCR. The sensitivity and specificity
of the pdm09-ICA were 75.86% (110/145) and 100%
(43/43), respectively (Table 3). The positive rates of the
pdm09-ICA, according to the crossing point (CP) valuesTable 4. The positive rates of pdm09-ICA according to the cro
Real-time PCR No. of
CP interval No. of positive Positive
<20 22 21
20e25 69 61
25e30 34 23
>30 20 5
Total 145 110
CP Z crossing point; ICA Z immunochromatographic assay; RT-PCR Z reof rRT-PCR, are presented in Table 4. As the CP values
of rRT-PCR increases, the sensitivity of the pdm09-ICA
decreases.4. Discussion
Influenza A viruses are made up of eight segments of
encoding proteins, namely, polymerase basic proteins 1
and 2 (PB1 and PB2), polymerase acidic protein, HA,
nucleoprotein (NP), neuraminidase, matrix proteins 1 and
2 (M1 andM2), and nonstructural proteins 1 and 2 [12,13].
Because HA genes are the most specific genes in the
genome of the influenza A virus subtype, the methods
based on viral RNA analysis target HA genes to diagnose
the pdm09 [7]. However, commercially available influenza
antigen tests do not distinguish the pdm09 from seasonal
influenza viruses because they use antibodies against the
NP of influenza A and B viruses [7,14]. For rapid and
specific detection of the pdm09 among seasonal viruses,
we have developed antibodies against theHAof the pdm09
and a variety of hybridoma cells, which produced HA-
specific monoclonal antibodies screened by the HI assay.
We selected one hybridoma producing secreted MAb that
showed excellent reactivity in the HI assay.
For the detection of seasonal influenza viruses,
several commercial influenza antigen tests have been
evaluated for pdm09. Compared with the rRT-PCR
analysis, the sensitivity and specificity were 48.7% and
96.5% [6], 47% and 96% [15], 53.4% and 100% [14],
respectively. The tests showed relatively low sensitivity
for the detection of pdm09. Thus, the development of assing point values of real-time RT-PCR
specimens with pdm09-ICA
Sensitivity(%)Negative
1 95.45
8 88.4
11 67.65
15 25
35 75.86
verse-transcription polymerase chain reaction.
346 M.J. Ji, et almore accurate ICA for the screening and diagnosis of
pdm09 infection is urgently needed [16]. In this study,
we have developed pdm09-ICA that is not only high in
sensitivity but also detectable to distinguish between the
pdm09 and seasonal influenza A and B viruses using
monoclonal antibodies against HA of the pdm09. The
pdm09-ICA developed in this study showed 75.86%
sensitivity, which is higher than the sensitivity of com-
mercial influenza antigen tests and 100% specificity
compared with rRT-PCR results. When the CP value
was lower than 20, the sensitivity of the pdm09-ICA was
95.45%; however, when the CP value was higher than
30, the sensitivity of the pdm09-ICA decreased to 25%.
Therefore, the sensitivity of pdm09-ICA is closely
related with the viral number; thus, it will be useful in
the diagnosis of patients who have severe symptoms for
influenza [10]. In addition, pdm09-ICA had the speci-
ficity for pdm09; 19 of the 20 different influenza viruses
chosen did not show reactivity, except for H1N1 (A/
Swine/Korea/GC0503/2005), which showed a very
weak positive signal because the pdm09 was a result of a
reassortment with swine influenza A viruses [12,13].
The pdm 09-ICA can be easily used for rapid and
specific detection of the pdm09 virus from other influ-
enza A and B viruses, and positive signals can be visible
within 10e15 minutes without using any equipment in
the laboratory. This study suggests that the rapid diag-
nosis of the pdm09 by the pdm09-ICA might alternate
with PCR, which requires equipment, cost, and time.Acknowledgments
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